Sema4 - Transforming Diagnostic Testing Into An Information Business
Presented by BioHaven
Yale and CURE BioHaven present "Sema4 - Transforming Diagnostic Testing Into An Information Business." Originating from the Mount Sinai Health System in New York City, Sema4 is an interdisciplinary partnership of scientists, doctors, engineers, and genetic counselors. It has a foundation of more than 160 years of clinical experience, world-class academic research, and pioneering information science.
Senior Patent Agent Sandra Shaner, Ph.D. will attend. Sandra concentrates her practice primarily in the areas of biotechnology, pharmaceuticals, food science, and material science. She has extensive experience in patent application preparation, domestic and international prosecution, and patent searching. She began her career as an Associate Research Scientist at Yale's Department of Human Genetics. Before joining Cantor Colburn, she also worked for Genaissance Pharmaceuticals.